Highlights and Quick Summary
- Total current assets for the quarter ending September 30, 2022 was $509 Million (a 2.86% increase compared to previous quarter)
- Year-over-year quarterly Total current assets decreased by -10.09%
- Annual Total current assets for 2021 was $566 Million (a 74.84% increase from previous year)
- Annual Total current assets for 2020 was $324 Million (a 97.02% increase from previous year)
- Annual Total current assets for 2019 was $164 Million (a 43.72% increase from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total current assets of BioCryst Pharmaceuticals, Inc.
Most recent Total current assetsof BCRX including historical data for past 10 years.Interactive Chart of Total current assets of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Total current assets for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $509.0 | $494.85 | $511.71 | – |
| 2021 | $566.14 | $252.74 | $265.8 | $273.77 | $566.14 |
| 2020 | $323.8 | $162.44 | $203.84 | $125.51 | $323.8 |
| 2019 | $164.35 | $78.8 | $103.72 | $117.65 | $164.35 |
| 2018 | $114.35 | $128.5 | $92.67 | $104.16 | $114.35 |
| 2017 | $125.39 | $175.37 | $92.26 | $113.5 | $125.39 |
| 2016 | $66.99 | $64.63 | $46.11 | $50.43 | $66.99 |
| 2015 | $63.79 | $84.5 | $107.09 | $81.37 | $63.79 |
| 2014 | $89.34 | $135.14 | $138.25 | $35.73 | $89.34 |
| 2013 | $42.12 | $46.84 | $33.53 | $35.41 | $42.12 |
| 2012 | $41.98 | $46.58 | $45.06 | $52.95 | $41.98 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology